Retrospective Study
Copyright ©The Author(s) 2023.
World J Clin Cases. Aug 16, 2023; 11(23): 5447-5454
Published online Aug 16, 2023. doi: 10.12998/wjcc.v11.i23.5447
Table 1 Comparison of cumulative survival rates of 200 patients with endometrial cancer based on clinical characteristics
Clinical features
n
Cumulative survival rate (%)
χ2 value
P value
Age (yr)
< 508497.45.8970.002
≥ 5011681.5
Non-menopausal8196.86.7930.008
Menopausal11987.5
Pregnancy history
Yes15590.40.6340.269
None45100.0
Comorbidities
Polycystic ovary syndrome
Yes33100.00.3100.454
None16890.6
High blood pressure
Yes8188.10.6000.358
None11992.1
Obesity
Post-operative adjuvant radiotherapy7985.71.0620.280
12192.1
Post-operative medroxyprogesterone acetate treatment7285.70.6730.195
12880.0
Co-Medroxyprogesterone Acetate6196.64.5520.047
Not combined with medroxyprogesterone acetate13981.0
Type of pathology
Adenocarcinoma14495.6
Adenosquamous carcinoma1037.532.321< 0.001

Non-adenocarcinoma

Typing

777.8